Can host receptors for fungi be targeted for treatment of fungal infections?

Trends in Microbiology

Volumn 21, Issue 8, 2013, Pages 389-396

  Filler, Scott G ^a,b  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelial cells; Epithelial cells; Fungi; Pathogenesis; Receptor

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 9; CD14 ANTIGEN; CELL RECEPTOR; CXCL2 CHEMOKINE; DECTIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FUNGAL PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLYCOPROTEIN GP 96; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; LACTOSYLCERAMIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE CELL ADHESION MOLECULE; RECEPTOR OF HYALURONAN MEDIATED MOTILITY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

CANDIDA ALBICANS; CANDIDIASIS; CELL INTERACTION; CELL INVASION; CELL STIMULATION; CELL SURFACE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFICACY; DRUG TARGETING; ENDOCYTOSIS; ENDOTHELIUM CELL; EPITHELIUM CELL; FUNGAL CELL; HOST CELL; HUMAN; IN VITRO STUDY; INFLAMMATION; MUCORMYCOSIS; MYCOSIS; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; RHIZOPUS ORYZAE;

ENDOTHELIAL CELLS; EPITHELIAL CELLS; FUNGI; PATHOGENESIS; RECEPTOR;

ANIMALS; CANDIDA ALBICANS; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; ENDOTHELIAL CELLS; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; MYCOSES; RHIZOPUS;

ANIMALIA; CANDIDA ALBICANS; FUNGI; RHIZOPUS ORYZAE;

EID: 84881022393     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.05.006     Document Type: Review

References (65)

1. Alkhatib G., et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
2. Dean M., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273:1856-1862.
3. Gulick R.M., et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N. Engl. J. Med. 2008, 359:1429-1441.
4. Pappas P.G., et al. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 2004, 38:161-189.
5. Wisplinghoff H., et al. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin. Microbiol. Infect. 2006, 12:170-177.
6. Grubb S.E., et al. Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect. Immun. 2008, 76:4370-4377.
7. Rotrosen D., et al. Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration. J. Infect. Dis. 1985, 152:1264-1274.
8. Montes L.F., Wilborn W.H. Ultrastructural features of host-parasite relationship in oral candidiasis. J. Bacteriol. 1968, 96:1349-1356.
9. Reichart P.A., et al. Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J. Oral Pathol. Med. 1995, 24:276-281.
10. Park H., et al. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell. Microbiol. 2005, 7:499-510.
11. Zakikhany K., et al. In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol. 2007, 9:2938-2954.
12. Filler S.G., et al. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 1995, 63:976-983.
13. Phan Q.T., et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007, 5:e64.
14. Sun J.N., et al. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 2010, 6:e1001181.
15. Zhu W., et al. EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:14194-14199.
16. Moreno-Ruiz E., et al. Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell. Microbiol. 2009, 11:1179-1189.
17. Phan Q.T., et al. N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J. Biol. Chem. 2005, 280:10455-10461.
18. Luo Y., Radice G.L. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J. Cell Biol. 2005, 169:29-34.
19. Yarom N., et al. Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors. Curr. Clin. Pharmacol. 2013, 8:81-88.
20. Liu Y., et al. Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog. 2011, 7:e1002305.
21. Ariyachet C., et al. SR-like RNA-binding protein Slr1 affects Candida albicans filamentation and virulence. Infect. Immun. 2013, 81:1267-1276.
22. Pfaller M., et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagn. Microbiol. Infect. Dis. 2012, 74:323-331.
23. Cleveland A.A., et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin. Infect. Dis. 2012, 55:1352-1361.
24. Li L., Dongari-Bagtzoglou A. Epithelial GM-CSF induction by Candida glabrata. J. Dent. Res. 2009, 88:746-751.
25. Iwabuchi K., et al. Membrane microdomains in immunity: glycosphingolipid-enriched domain-mediated innate immune responses. Biofactors 2012, 38:275-283.
26. Park B.J., et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
27. Barbosa F.M., et al. Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production. Clin. Vaccine Immunol. 2007, 14:94-98.
28. Barbosa F.M., et al. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microbes Infect. 2006, 8:493-502.
29. Charlier C., et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 2009, 77:120-127.
30. Stie J., Fox D. Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology 2012, 158:240-258.
31. Shi M., et al. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J. Clin. Investig. 2010, 120:1683-1693.
32. Tseng H.K., et al. Identification of genes from the fungal pathogen Cryptococcus neoformans related to transmigration into the central nervous system. PLoS ONE 2012, 7:e45083.
33. Jong A., et al. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell. Microbiol. 2008, 10:1313-1326.
34. Chang Y.C., et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect. Immun. 2004, 72:4985-4995.
35. Chretien F., et al. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 2002, 186:522-530.
36. Jong A., et al. Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J. Biol. Chem. 2012, 287:15298-15306.
37. Jong A., et al. Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot. Cell 2007, 6:1486-1496.
38. Chang Y.C., et al. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect. Immun. 2006, 74:3930-3938.
39. Huang S.H., et al. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3). J. Biol. Chem. 2011, 286:34761-34769.
40. Long M., et al. Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells. J. Biomed. Sci. 2012, 19:19.
41. Jong A., et al. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation. Cell. Microbiol. 2008, 10:1854-1865.
42. Pilarski L.M., et al. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells. Blood 1999, 93:2918-2927.
43. Ibrahim A.S., et al. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect. Immun. 2005, 73:778-783.
44. Liu M., et al. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J. Clin. Investig. 2010, 120:1914-1924.
45. Osherov N. Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells. Front. Microbiol. 2012, 3:26.
46. Ejzykowicz D.E., et al. Role of Aspergillus fumigatus DvrA in host cell interactions and virulence. Eukaryot. Cell 2010, 9:1432-1440.
47. Steele C., et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 2005, 1:9.
48. Hohl T.M., et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog. 2005, 1:e30.
49. Han X., et al. beta-1,3-Glucan-induced host phospholipase D activation is involved in Aspergillus fumigatus internalization into type II human pneumocyte A549 cells. PLoS ONE 2011, 6:8.
50. Sun W.K., et al. Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:2755-2764.
51. Cunha C., et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 2010, 116:5394-5402.
52. Ferwerda B., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 2009, 361:1760-1767.
53. Xu X.Y., et al. E-cadherin mediates adhesion and endocytosis of Aspergillus fumigatus blastospores in human epithelial cells. Chin. Med. J. 2012, 125:617-621.
54. Long E.G., et al. Attachment of Pneumocystis carinii to rat pneumocytes. Lab. Invest. 1986, 54:609-615.
55. Hahn P.Y., et al. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 2003, 278:2043-2050.
56. Wang J., et al. Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:16.
57. Bozzette S.A., et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N. Engl. J. Med. 1990, 323:1451-1457.
58. Gagnon S., et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N. Engl. J. Med. 1990, 323:1444-1450.
59. Carmona E.M., et al. Pneumocystis cell wall beta-glucan stimulates calcium-dependent signaling of IL-8 secretion by human airway epithelial cells. Respir. Res. 2010, 11:1465-9921.
60. Bello-Irizarry S.N., et al. The alveolar epithelial cell chemokine response to Pneumocystis requires adaptor molecule MyD88 and interleukin-1 receptor but not toll-like receptor 2 or 4. Infect. Immun. 2012, 80:3912-3920.
61. Evans S.E., et al. Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am. J. Respir. Cell Mol. Biol. 2005, 32:490-497.
62. Evans S.E., et al. Primary alveolar epithelial cell surface membrane microdomain function is required for Pneumocystis beta-glucan-induced inflammatory responses. Innate Immun. 2012, 18:709-716.
63. Flaherty K.T., et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N. Engl. J. Med. 2012, 367:1694-1703.
64. Kremer J.M., et al. A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone. Arthritis Rheum. 2012, 64:970-981.
65. Napier R.J., et al. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe 2011, 10:475-485.